StockData
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31

VITASPRING BIOMEDICAL CO. LTD.

Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026
$0.03+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$6.58M
P/E (TTM)
–
Dividend yield
–

VITASPRING BIOMEDICAL CO. LTD. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Vitaspring Biomedical does not break out revenue by segment, region or product in the tagged data of its filings for this period type.